Firms

Swinburne Ventures
Swinburne Ventures Ltd (also styled Swinburne Ventures Limited), ABN47096584404 and ACN096584404, is Swinburne University of Technology’s controlled commercial-investment arm in Australia. University reporting identifies a company limited by guarantee and 100% university control; it is distinct from the parent university and does not imply a stock-exchange listing. It supports technology-based pre-seed and seed ventures, research spin-outs and equity-based commercialisation partnerships. Its disclosed portfolio includes CogTx neuroscience software, Novapep neurodegenerative therapeutics, EntroMat advanced materials, Fluency documentation software, Vidversity digital learning and Vycarb carbon-removal technology. Werner van der Merwe is publicly identified as chair. The associated Innovation Studio and Commercial Innovation team provide commercialisation support; their university titles are explicitly qualified rather than presented as all being employees or directors of the legal investment company. The image is the authentic shared university brand used on its investment/commercialisation pages; no separate unit logo is published. No external final fund close amount or date is verified.
- Founded
- —
- Type
- Venture capital
Funds0
No funds on record yet.
Team
Operations and support
Co-investing
No co-investors on record yet.


